Modern In vitro Diagnostics at the BIOTECHNICA 2011

The Fraunhofer IBMT as one of the six institutes within the Fraunhofer Group of Life Sciences is a provider of in vitro diagnostics (ivD) related research and development tools.

Among its services, the whole value chain from biomarker to a marketable ivD-platform can be covered. Starting with a collection of biospecimen (cyrotechnology) and access via a metadatabase (CRIP) to a multiply of pathologies around Europe the Fraunhofer IBMT starts to find biomarker for different indications.

Having a biomarker, different assay development tools combining sensor technology, microarray techniques and different platforms (lab-on-a-chip) can be chosen to obtain a marketable diagnostic test.

Contact
Dr. Eva Ehrentreich-Förster
Molecular Bioanalytics & Bioelectronics
Fraunhofer Institute for Biomedical Engineering IBMT
Branch Golm
Am Mühlenberg 13
14476 Potsdam-Golm, Germany
Tel.: +49 331 / 58187 – 203
Fax: +49 331 / 58187 – 299
eva.ehrentreich@ibmt.fraunhofer.de

Media Contact

Annette Maurer Fraunhofer-Institut

More Information:

http://www.ibmt.fraunhofer.de

All latest news from the category: Trade Fair News

Back to home

Comments (0)

Write a comment

Newest articles

Cancer predisposition syndromes in children and adolescents.

Decoding Cancer: 40 Years of Breakthroughs in Genetic Research

Cancer in children and adolescents is rare. Nevertheless, malignant diseases are still one of the most common causes of death in this age group. Survivors of childhood or adolescent cancer…

Brain structure differences in adolescents at risk of early substance initiation

Let’s Think Before the First Drink: How Early Substance Use Might Lead to Brain Structure Differences Among Adolescents

Many differences appeared to exist prior to any substance use, pointing to the role brain structure may play in substance use risk, NIH-supported study suggests. Studies reveal factors that expose…

Innovative immunotherapy strategies for improving kidney cancer detection and treatment.

Combating Kidney Cancer Using Enhanced Immunotherapies

Medical University of South Carolina Hollings Cancer Center researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors. A Medical University of…